Navigation Links
Oxford Performance Materials Acquired By Arkema

OPM Expands Position within High Performance Polymer Market Place

Enfield, CT (PRWEB) February 9, 2009 -- Arkema has announced the acquisition of Oxford Performance Materials, Inc. (OPM), maker of OXPEKK® products. OPM will operate as an Arkema subsidiary from its Enfield, CT headquarters with the established management team. The firm will continue its commercial focus on advanced medical and industrial applications for its proprietary materials. OXPEKK® products are currently used in commercial jetliners, long-term medical implants, and demanding energy applications, including down-hole tools and pumps.

OXPEKK® polyether ketone ketone is a high-temperature and chemically resistant, semi-crystalline thermoplastic with exceptional abrasion resistance and natural flame retardancy. "The addition of OXPEKK® products to Arkema's diverse portfolio complements a set of high-performance plastics than include high-purity Kynar® Rx PVDF, biocompatible Pebax® polyether block amides, medical-grade Plexiglas® PMMA, and food-contact-compliant Biostrength® polymer additives," said Homero Endara, commercial development manager for Arkema, Inc.

"Arkema has had a long-standing interest in ultra-high-performance polymers and we have looked at strategic opportunities in the past. It was our desire to find the right combination of management committed to exploiting the medical and high-tech market space and a product that offered outstanding technical differentiation," said Ryan Dirkx, V.P. of Research and Development for Arkema, Inc. "We are delighted to have concluded this transaction and look forward to supporting OPM with the capabilities of Arkema's global organization."

"OPM has spent nearly ten years perfecting the polyethyl ketone ketone (PEKK) molecule with the help of venture capital," said Scott DeFelice, President and CEO of OPM. "Now with Arkema, we can broaden our industrial strategy and pursue more market opportunities. OPM's single-minded focus on PEKK and Arkema's polymer competencies and capabilities will be a formidable combination in the high-performance polymer marketplace."

About OPM
Founded in March 2000, OPM has rapidly become an industry leader in the ultra-high performance thermoplastic polymers market. The firm's versatile OXPEKK® polymers are currently being used in medical, space and defense, semiconductor and industrial markets worldwide. OPM is ISO 9001:2000 and ISO 13485:2003 registered. For additional information, please visit

About Arkema
A global chemical company and France's leading chemicals producer, Arkema consists of three strategically related businesses: Vinyl Products, Industrial Chemicals, and Performance Products. Arkema reported sales of 5.7 billion euros in 2007. Arkema has 15,200 employees across over 40 countries and six research centers located in France, the United States and Japan. With internationally recognized brands, Arkema holds leadership positions in its principal markets.

OXPEKK® is a registered trademark belonging to Oxford Performance Materials, Inc.
Kynar® and Biostrength® are trademarks belonging to Arkema, Inc.
Pebax® is a trademark belonging to Arkema.
Plexiglas® is a trademark belonging to Altuglas International.

# # #

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Oxford Performance Materials Received ISO 13485 and ISO 9001 Certification
2. AIDS Activists from Across the Country Converge on Oxford, Mississippi, to Call on McCain and Obama to Commit to National AIDS Strategy
3. Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
4. Varian, Inc. Acquires Oxford Diffraction, Ltd.
5. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
6. Journal of American College of Surgeons study finds warm-up helps surgeons improve performance
7. Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009
8. KPMG and Trintech Collaborate to Enable Bay Area Users Group of Trintech Customers to Optimize Their Investments in Technology and Deliver Improved Performance in Turbulent Economic Times
9. AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan
10. Synthetech Earns National Recognition for Performance Improvement Program
11. Park Avenue Nursing and Rehabilitation Center Selects Web-based Long-Term Care Software to Automate Admissions and Boost Census Performance
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... at the Radiological Society of North America (RSNA) 2015 conference. , Leading ... dictation and speech-enabled documentation software, announced their partnership today at RSNA 2015. ...
(Date:11/30/2015)... ... 30, 2015 , ... World Patent Marketing , a ... household invention that provides an economical and easy way of gaining customized curtains. ... at 2.6%," says Scott Cooper, CEO and Creative Director of World Patent Marketing. ...
(Date:11/29/2015)... St. Petersburg, FL (PRWEB) , ... November 30, ... ... beauty are available today from the new company, Sublime Beauty NATURALS®. All products ... organic and natural products, like essential oils, organic facial serums and USDA Certified ...
(Date:11/29/2015)... ... ... The Cyber Monday deal is a deep 40% or more discount on every item on ... the skin care lover in your circle. Each Christmas, Sublime Beauty offers a special ... serums are staples: Collagen, Retinol and Hyaluronic Serums. , Stocking stuffers like Skin Brushes, natural ...
(Date:11/29/2015)... , ... November 29, 2015 , ... While conventional walkers ... or provide ready access to exercise weights. Fortunately, an inventor from Uniontown, Pa., has ... TOMMY WALKER to enhance the benefits of a standard walker to improve the user’s ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 27, 2015  Lannett Company, Inc. (NYSE: ... the acquisition of Kremers Urban Pharmaceuticals Inc. (KU), ... biopharmaceuticals company UCB S.A. (Euronext: UCB). ... acquired KU from UCB for total consideration of ... a customary working capital adjustment, a deduction of ...
(Date:11/26/2015)... november 2015 AAIPharma Services Corp./Cambridge ... investering aan van ten minste $15,8 miljoen ... het mondiale hoofdkantoor in Wilmington, ... in extra kantoorruimte en extra capaciteit voor ... behoeften van de farmaceutische en biotechnologische markten. ...
(Date:11/26/2015)... 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ... is expected to boost the market growth, as 3D bioprinting ... --> 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ...
Breaking Medicine Technology: